查看购物车
  • Traditional Chinese
  • English
  • Japanese
  • Korean
封面
市场调查报告书
商品编码
1636671

2030 年食物过敏治疗市场预测：按过敏原类型、药物类型、给药途径、最终用户和地区进行的全球分析

Food Allergy Treatment Market Forecasts to 2030 - Global Analysis By Allergen Type (Dairy Products, Poultry Products, Tree Nuts, Peanuts, Shellfish, Wheat, Soys and Other Allergen Types), Drug Type, Route of Administration, End User and By Geography
出版日期: | 出版商: Stratistics Market Research Consulting | 英文 200+ Pages | 商品交期: 2-3个工作天内

价格

根据 Stratistics MRC 的数据，2024 年全球食物过敏治疗市场价值将达到 71.3 亿美元，预计在预测期内复合年增长率为 10.27%，到 2030 年将达到 128.1 亿美元。

食物过敏治疗主要着重于控制症状和预防严重反应。最好的策略是避免触发食物，但这很困难，因为过敏原存在于多种食物中。肾上腺素注射对于治疗过敏反应（一种可能致命的过敏反应）至关重要，但抗组织胺药物和皮质类固醇等药物可用于缓解轻微症状。免疫疗法是治疗食物过敏的另一个最新进展，患者随着时间的推移会接触少量过敏原并产生耐受性。

根据世界过敏组织 (WAO) 的数据，食物过敏影响全球约 2.2 亿至 2.5 亿人，其中 5 岁以下儿童的盛行率最高。

食物过敏的盛行率增加

食物过敏在世界各地变得越来越普遍，特别是在北美和欧洲等已开发地区。研究表明，儿童患有食物过敏的比例相当高，估计高达8%。由于多种因素，包括遗传、饮食变化、加工食品接触增加以及某些环境因素接触减少（卫生假说），食物过敏诊断数量不断增加。此外，病例数的增加增加了对有效治疗方法来控制症状和改善患者生活品质的需求。

昂贵的先进医疗服务

儘管免疫疗法和生物製药等有效的先进治疗方法通常需要长期给药和密切的医疗管理，从而导致高昂的医疗保健成本，这是治疗市场面临的主要挑战之一。免疫疗法可能需要数月或数年才能生效，而单株抗体等生技药品的製造和使用通常价格昂贵。此外，费用对许多患者来说可能是一个障碍，特别是那些低收入地区和没有足够医疗保险覆盖的患者，限制了获得先进治疗方法的机会并阻碍了他们的接受。

开发客製化治疗方法

食物过敏治疗越来越多地透过个人化医疗来进行。基因测试是更先进的诊断工具之一，使医疗保健相关人员能够根据每位患者的独特过敏情况制定量身定制的治疗方案。生物製药和免疫疗法是两个受益于此策略的治疗方法例子。个人化食物过敏治疗对患者来说也是一个有吸引力的选择，因为它可以采取更强化的方法，副作用更少。此外，对精准医学和基因组学的日益关注预计将刺激食物过敏治疗的进一步进步，并为市场扩张创造新的机会。

与现有治疗方法的激烈竞争

目前治疗方法的激烈竞争是食物过敏治疗市场面临的主要风险之一。对于食物过敏反应的管理，市面上有许多成熟的治疗方法，包括皮质类固醇、肾上腺素注射和抗组织胺。这些治疗方法众所周知且价格实惠，使得免疫疗法和生物製药等更新、更昂贵的治疗方法很难获得市场占有率。此外，这些众所周知的治疗方法的学名药的广泛使用造成了激烈的竞争，并且新产品进入市场的速度很慢，除非它们能提供显着的优越效果或更便宜。

COVID-19 的影响：

食物过敏治疗市场受到了 COVID-19 大流行的显着影响，无论是积极还是消极。一方面，疫情让人们更加意识到食物过敏等与健康相关的问题，并学会在不可预测的时期管理自己的整体健康和免疫力。但这场危机也为医疗保健系统带来了问题，许多患者的常规医生预约、过敏测试和治疗被推迟。临床试验和不必要的程序被推迟，影响了新治疗方法的开发和可用性。此外，许多患者无法亲自接受医疗护理，尤其是在封锁严重的地区，导致诊断和治疗的延误。

预计坚果市场在预测期内将是最大的市场

食物过敏治疗市场预计将由树坚果领域主导。腰果、核桃和杏仁等坚果是最常见的过敏原，因此对有效治疗解决方案的需求日益增长。这个细分市场的主导地位得到了人们对树坚果过敏的广泛认可，这种过敏可能会导致包括过敏反应在内的严重反应。因此，已经开发出肾上腺素注射剂和口服免疫疗法等过敏治疗方法来抑制和减少过敏反应。此外，该细分市场在更大的食物过敏治疗市场中的扩张是由于专门针对树坚果过敏而设计的医学研究和治疗方法的发展。

免疫治疗产业预计在预测期内复合年增长率最高

在食物过敏治疗市场中，免疫治疗领域预计将以最高的复合年增长率成长。免疫疗法能够逐渐使患者对过敏原脱敏，这使得口服免疫疗法（OIT）和舌下免疫疗法（SLIT）变得越来越受欢迎。透过培养对食物过敏原的耐受性，这种治疗策略可显着降低严重过敏反应的机会。免疫疗法（包括针对花生、木本坚果和贝类等常见过敏原）为食物过敏患者提供了长期益处，更多治疗方法正在临床试验中进行研究并获得监管机构的核准。

占比最大的地区：

预计北美地区将占据食物过敏治疗市场的最大份额。其主要原因是美国和加拿大等国家，食物过敏的发生率很高，尤其是儿童。其他优点包括该地区对医学研究和创新的重视、先进的医疗基础设施以及对食物过敏的普遍认识。由于正在进行的临床试验、监管核准以及免疫疗法等创新治疗方法的开发，北美在食物过敏治疗的收益和采用方面处于市场领先地位。此外，该地区的市场主导地位是由肾上腺素注射器和非处方抗组织胺的供应不断扩大所推动的。

复合年增长率最高的地区：

预计食物过敏治疗市场将以亚太地区 (APAC) 最高的复合年增长率成长。在中国、印度、日本和韩国等国家，都市化进程的加速、饮食习惯的改变以及对食物过敏的认识的提高是这一增长的主要驱动力。由于食物过敏被认为是一个严重的健康问题，因此越来越需要新的治疗方法，例如抗组织胺、肾上腺素注射和免疫疗法。此外，由于全部区域医疗保健投资的增加和医疗基础设施的进步，亚太地区一直是食物过敏治疗产业成长率最高的地区。

免费客製化服务：

订阅此报告的客户将收到以下免费自订选项之一：

  • 公司简介
    • 其他市场公司的综合分析（最多 3 家公司）
    • 主要企业SWOT分析（最多3家企业）
  • 区域分割
    • 根据客户兴趣对主要国家的市场估计、预测和复合年增长率（註：基于可行性检查）
  • 竞争标基准化分析
    • 根据产品系列、地理分布和策略联盟对主要企业基准化分析

目录

第一章执行摘要

第二章 前言

  • 概述
  • 相关利益者
  • 调查范围
  • 调查方法
    • 资料探勘
    • 资料分析
    • 资料检验
    • 研究途径
  • 研究资讯来源
    • 主要研究资讯来源
    • 二次研究资讯来源
    • 先决条件

第三章市场趋势分析

  • 促进因素
  • 抑制因素
  • 机会
  • 威胁
  • 最终用户分析
  • 新兴市场
  • COVID-19 的影响

第4章波特五力分析

  • 供应商的议价能力
  • 买方议价能力
  • 替代品的威胁
  • 新进入者的威胁
  • 竞争公司之间的敌对关係

第五章全球食物过敏治疗市场：依过敏原类型

  • 乳製品
  • 家禽产品
  • 坚果
  • 花生
  • 贝类
  • 小麦
  • 大豆
  • 其他过敏原类型

第六章全球食物过敏治疗市场：依药物类型

  • 抗组织胺药
  • 减充血剂
  • 皮质类固醇
  • 肥大细胞稳定剂
  • 白三烯抑制剂
  • 鼻用抗胆碱能药物
  • 免疫调节剂
  • 肾上腺素
  • 免疫疗法
  • 其他药物类型

第七章全球食物过敏治疗市场：依给药途径

  • 口服
  • 胃肠外的
  • 其他给药途径

第八章全球食物过敏治疗市场：依最终用户分类

  • 医院药房
  • 零售药房
  • 其他最终用户

第九章全球食物过敏治疗市场：按地区

  • 北美洲
    • 美国
    • 加拿大
    • 墨西哥
  • 欧洲
    • 德国
    • 英国
    • 义大利
    • 法国
    • 西班牙
    • 其他欧洲国家
  • 亚太地区
    • 日本
    • 中国
    • 印度
    • 澳洲
    • 纽西兰
    • 韩国
    • 其他亚太地区
  • 南美洲
    • 阿根廷
    • 巴西
    • 智利
    • 南美洲其他地区
  • 中东/非洲
    • 沙乌地阿拉伯
    • 阿拉伯聯合大公国
    • 卡达
    • 南非
    • 其他中东/非洲

第10章 主要进展

  • 合约、伙伴关係、协作和合资企业
  • 收购和合併
  • 新产品发布
  • 业务拓展
  • 其他关键策略

第十一章 公司概况

  • Alladapt Immunotherapeutics, Inc.
  • F. Hoffman-La Roche Ltd.
  • Prota Therapeutics Pty Ltd
  • COUR Pharmaceuticals Development Company, Inc
  • Novartis Pharmaceuticals
  • Teva Pharmaceutical Industries Ltd.
  • DBV Technologies
  • Stallergenes Greer International AG
  • Aravax
  • Vedanta Biosciences, Inc.
  • Sanofi
  • Neogen Corporation
  • AstraZeneca
  • Mylan NV
  • Cambridge Allergy Ltd.
Product Code: SMRC28312

According to Stratistics MRC, the Global Food Allergy Treatment Market is accounted for $7.13 billion in 2024 and is expected to reach $12.81 billion by 2030 growing at a CAGR of 10.27% during the forecast period. Food allergy treatment primarily focuses on managing symptoms and preventing severe reactions. The best strategy is to stay away from trigger foods, but this can be difficult because allergens are present in many different foods. While epinephrine (adrenaline) injections are essential for treating anaphylaxis, a potentially fatal allergic reaction, medications such as antihistamines and corticosteroids may be used to relieve mild symptoms. Immunotherapy is another recent development in the treatment of food allergies, in which patients are exposed to trace amounts of the allergen over time to develop tolerance.

According to the World Allergy Organization (WAO), approximately 220-250 million people globally suffer from food allergies, with the highest prevalence seen in children under the age of 5.

Market Dynamics:

Driver:

Growing food allergy prevalence

Food allergies have been becoming more and more common worldwide, especially in developed areas like North America and Europe. Research shows that a sizable percentage of kids suffer from food allergies; estimates range as high as 8% for this population. The number of food allergy diagnoses is rising due to a number of factors, including genetics, dietary changes, increased exposure to processed foods, and decreased exposure to some environmental factors (hygiene hypothesis). Moreover, the increase in cases is raising the need for efficient therapies that can help patients manage their symptoms and enhance their quality of life.

Restraint:

Expensive advanced medical care

The high cost of advanced therapies, like immunotherapy and biologics, which, although effective, often require long-term administration and close medical supervision, resulting in substantial healthcare costs, is one of the major challenges facing the food allergy treatment market. Immunotherapy treatments can take months or even years to show results, and biologics, such as monoclonal antibodies, are typically expensive to produce and administer. Additionally, the cost can be a barrier for many patients, especially those in low-income regions or those without adequate health insurance coverage, which limits access to advanced therapies and prevents their widespread adoption.

Opportunity:

Development of tailored therapy methods

The treatment of food allergies is increasingly being approached through personalized medicine. Genetic testing is one of the more advanced diagnostic tools that have made it possible for medical professionals to create customized treatment programs that are suited to each patient's unique allergies. Biologics and immunotherapy are two examples of treatments that benefit from this strategy. Personalized food allergy treatments are also a more appealing option for patients because they provide a more focused approach with fewer side effects. Furthermore, the increasing emphasis on precision medicine and genomics is anticipated to spur additional advancements in food allergy therapies, creating new opportunities for market expansion.

Threat:

Intense competition from existing therapies

The fierce competition from current treatments is one of the major risks facing the market for food allergy treatments. For the management of food allergy reactions, the market offers a wide range of well-established treatments, such as corticosteroids, epinephrine injections, and antihistamines. Because these treatments are well-known and reasonably priced, it is difficult for more recent and costly treatments like immunotherapy and biologics to increase their market share. Moreover, the fierce competition created by the widespread availability of generic versions of these well-known medications makes it more difficult for new products to take off unless they provide noticeably better advantages or are more affordable.

Covid-19 Impact:

The market for food allergy treatments was significantly impacted by the COVID-19 pandemic, both positively and negatively. On the one hand, the pandemic raised people's awareness of health-related problems, such as food allergies, as they learned to manage their general well-being and immunity in unpredictable times. But the crisis also caused problems for healthcare systems, causing many patients' regular doctor's appointments, allergy tests, and treatments to be postponed. Clinical trials and non-essential procedures were delayed, which had an impact on the creation and accessibility of novel treatments. Furthermore, a lot of patients had trouble getting in-person consultations, especially in areas with stringent lockdowns, which caused delays in diagnosis and treatment.

The Tree Nuts segment is expected to be the largest during the forecast period

The food allergy treatment market is expected to be largest share by the tree nuts segment. Since tree nuts like cashews, walnuts, and almonds are among the most common allergens, there is a greater need for efficient treatment solutions. The broad awareness of tree nut allergies, which can result in severe reactions, including anaphylaxis, is what propels the segment's dominance. As a result, allergy treatments like epinephrine injections and oral immunotherapy have been developed to control and lessen allergic reactions. Additionally, the expansion of this market segment within the larger food allergy treatment market is being driven by developments in medical research and treatments designed especially to address tree nut allergies.

The Immunotherapy segment is expected to have the highest CAGR during the forecast period

In the food allergy treatment market, the immunotherapy segment is anticipated to grow at the highest CAGR. Because immunotherapy has the ability to gradually desensitize patients to allergens, it is becoming increasingly popular, especially oral immunotherapy (OIT) and sublingual immunotherapy (SLIT). By fostering tolerance to food allergens, this therapeutic strategy considerably lowers the likelihood of severe allergic reactions. Immunotherapy provides long-term benefits for patients with food allergies, including those to common allergens like peanuts, tree nuts, and shellfish, as clinical research continues to advance and more treatments are approved by regulators.

Region with largest share:

The Food Allergy Treatment Market is expected to be the largest share by the North American region. The main cause of this is the high incidence of food allergies, especially in children, in nations like the US and Canada. Additionally, the area benefits from a strong emphasis on medical research and innovation, a sophisticated healthcare infrastructure, and general awareness of food allergies. North America leads the market in terms of revenue and adoption of food allergy treatments due to ongoing clinical trials, regulatory approvals, and the development of innovative treatments like immunotherapy. Moreover, the region's dominant market position is facilitated by the expanding availability of epinephrine injectors and over-the-counter antihistamines.

Region with highest CAGR:

The food allergy treatment market is anticipated to grow at the highest CAGR in the Asia Pacific (APAC) region. In nations like China, India, Japan, and South Korea, growing urbanization, dietary changes, and growing awareness of food allergies are the main causes of this growth. The need for treatments like antihistamines, epinephrine injectors, and newer therapies like immunotherapy is rising as food allergies are acknowledged as a serious health issue. Furthermore, APAC is now the region with the fastest rate of growth in the food allergy treatment industry owing to rising healthcare investments and advancements in medical infrastructure throughout the region.

Key players in the market

Some of the key players in Food Allergy Treatment market include Alladapt Immunotherapeutics, Inc., F. Hoffman-La Roche Ltd., Prota Therapeutics Pty Ltd, COUR Pharmaceuticals Development Company, Inc, Novartis Pharmaceuticals, Teva Pharmaceutical Industries Ltd., DBV Technologies, Stallergenes Greer International AG, Aravax, Vedanta Biosciences, Inc., Sanofi, Neogen Corporation, AstraZeneca, Mylan N.V. and Cambridge Allergy Ltd.

Key Developments:

In December 2024, Teva Pharmaceutical Industries Ltd. announced that it has entered into an agreement with JKI, established by the fund managed and operated by J-Will, whereby all shares of Teva Takeda Pharma Limited and its wholly owned subsidiary Teva Takeda Yakuhin Ltd. will be transferred to JKI.

In September 2024, Sanofi has entered into an exclusive licensing agreement with RadioMedix, Inc., a US clinical-stage biotechnology company developing radiopharmaceuticals for PET imaging and targeted alpha therapy (TAT) against unmet medical needs in cancer, and Orano Med, a French clinical-stage biotechnology company, subsidiary of the Orano Group, developing lead-212 (212Pb) radioligand therapies (RLTs) against cancer.

In February 2024, Novartis announced that it has entered into an agreement to make a voluntary public takeover offer to acquire MorphoSys AG, a Germany-based, global biopharmaceutical company developing innovative medicines in oncology.

Allergen Types Covered:

  • Dairy Products
  • Poultry Products
  • Tree Nuts
  • Peanuts
  • Shellfish
  • Wheat
  • Soys
  • Other Allergen Types

Drug Types Covered:

  • Antihistamines
  • Decongestants
  • Corticosteroids
  • Mast Cell Stabilizers
  • Leukotriene Inhibitors
  • Nasal Anti-cholinergic
  • Immuno-modulators
  • Epinephrine
  • Immunotherapy
  • Other Drug Types

Route of Administrations Covered:

  • Oral
  • Parenteral
  • Other Route of Administrations

End Users Covered:

  • Hospital Pharmacies
  • Retail Pharmacies
  • Other End Users

Regions Covered:

  • North America
    • US
    • Canada
    • Mexico
  • Europe
    • Germany
    • UK
    • Italy
    • France
    • Spain
    • Rest of Europe
  • Asia Pacific
    • Japan
    • China
    • India
    • Australia
    • New Zealand
    • South Korea
    • Rest of Asia Pacific
  • South America
    • Argentina
    • Brazil
    • Chile
    • Rest of South America
  • Middle East & Africa
    • Saudi Arabia
    • UAE
    • Qatar
    • South Africa
    • Rest of Middle East & Africa

What our report offers:

  • Market share assessments for the regional and country-level segments
  • Strategic recommendations for the new entrants
  • Covers Market data for the years 2022, 2023, 2024, 2026, and 2030
  • Market Trends (Drivers, Constraints, Opportunities, Threats, Challenges, Investment Opportunities, and recommendations)
  • Strategic recommendations in key business segments based on the market estimations
  • Competitive landscaping mapping the key common trends
  • Company profiling with detailed strategies, financials, and recent developments
  • Supply chain trends mapping the latest technological advancements

Free Customization Offerings:

All the customers of this report will be entitled to receive one of the following free customization options:

  • Company Profiling
    • Comprehensive profiling of additional market players (up to 3)
    • SWOT Analysis of key players (up to 3)
  • Regional Segmentation
    • Market estimations, Forecasts and CAGR of any prominent country as per the client's interest (Note: Depends on feasibility check)
  • Competitive Benchmarking
    • Benchmarking of key players based on product portfolio, geographical presence, and strategic alliances

Table of Contents

1 Executive Summary

2 Preface

  • 2.1 Abstract
  • 2.2 Stake Holders
  • 2.3 Research Scope
  • 2.4 Research Methodology
    • 2.4.1 Data Mining
    • 2.4.2 Data Analysis
    • 2.4.3 Data Validation
    • 2.4.4 Research Approach
  • 2.5 Research Sources
    • 2.5.1 Primary Research Sources
    • 2.5.2 Secondary Research Sources
    • 2.5.3 Assumptions

3 Market Trend Analysis

  • 3.1 Introduction
  • 3.2 Drivers
  • 3.3 Restraints
  • 3.4 Opportunities
  • 3.5 Threats
  • 3.6 End User Analysis
  • 3.7 Emerging Markets
  • 3.8 Impact of Covid-19

4 Porters Five Force Analysis

  • 4.1 Bargaining power of suppliers
  • 4.2 Bargaining power of buyers
  • 4.3 Threat of substitutes
  • 4.4 Threat of new entrants
  • 4.5 Competitive rivalry

5 Global Food Allergy Treatment Market, By Allergen Type

  • 5.1 Introduction
  • 5.2 Dairy Products
  • 5.3 Poultry Products
  • 5.4 Tree Nuts
  • 5.5 Peanuts
  • 5.6 Shellfish
  • 5.7 Wheat
  • 5.8 Soys
  • 5.9 Other Allergen Types

6 Global Food Allergy Treatment Market, By Drug Type

  • 6.1 Introduction
  • 6.2 Antihistamines
  • 6.3 Decongestants
  • 6.4 Corticosteroids
  • 6.5 Mast Cell Stabilizers
  • 6.6 Leukotriene Inhibitors
  • 6.7 Nasal Anti-cholinergic
  • 6.8 Immuno-modulators
  • 6.9 Epinephrine
  • 6.10 Immunotherapy
  • 6.11 Other Drug Types

7 Global Food Allergy Treatment Market, By Route of Administration

  • 7.1 Introduction
  • 7.2 Oral
  • 7.3 Parenteral
  • 7.4 Other Route of Administrations

8 Global Food Allergy Treatment Market, By End User

  • 8.1 Introduction
  • 8.2 Hospital Pharmacies
  • 8.3 Retail Pharmacies
  • 8.4 Other End Users

9 Global Food Allergy Treatment Market, By Geography

  • 9.1 Introduction
  • 9.2 North America
    • 9.2.1 US
    • 9.2.2 Canada
    • 9.2.3 Mexico
  • 9.3 Europe
    • 9.3.1 Germany
    • 9.3.2 UK
    • 9.3.3 Italy
    • 9.3.4 France
    • 9.3.5 Spain
    • 9.3.6 Rest of Europe
  • 9.4 Asia Pacific
    • 9.4.1 Japan
    • 9.4.2 China
    • 9.4.3 India
    • 9.4.4 Australia
    • 9.4.5 New Zealand
    • 9.4.6 South Korea
    • 9.4.7 Rest of Asia Pacific
  • 9.5 South America
    • 9.5.1 Argentina
    • 9.5.2 Brazil
    • 9.5.3 Chile
    • 9.5.4 Rest of South America
  • 9.6 Middle East & Africa
    • 9.6.1 Saudi Arabia
    • 9.6.2 UAE
    • 9.6.3 Qatar
    • 9.6.4 South Africa
    • 9.6.5 Rest of Middle East & Africa

10 Key Developments

  • 10.1 Agreements, Partnerships, Collaborations and Joint Ventures
  • 10.2 Acquisitions & Mergers
  • 10.3 New Product Launch
  • 10.4 Expansions
  • 10.5 Other Key Strategies

11 Company Profiling

  • 11.1 Alladapt Immunotherapeutics, Inc.
  • 11.2 F. Hoffman-La Roche Ltd.
  • 11.3 Prota Therapeutics Pty Ltd
  • 11.4 COUR Pharmaceuticals Development Company, Inc
  • 11.5 Novartis Pharmaceuticals
  • 11.6 Teva Pharmaceutical Industries Ltd.
  • 11.7 DBV Technologies
  • 11.8 Stallergenes Greer International AG
  • 11.9 Aravax
  • 11.10 Vedanta Biosciences, Inc.
  • 11.11 Sanofi
  • 11.12 Neogen Corporation
  • 11.13 AstraZeneca
  • 11.14 Mylan N.V.
  • 11.15 Cambridge Allergy Ltd.

List of Tables

  • Table 1 Global Food Allergy Treatment Market Outlook, By Region (2022-2030) ($MN)
  • Table 2 Global Food Allergy Treatment Market Outlook, By Allergen Type (2022-2030) ($MN)
  • Table 3 Global Food Allergy Treatment Market Outlook, By Dairy Products (2022-2030) ($MN)
  • Table 4 Global Food Allergy Treatment Market Outlook, By Poultry Products (2022-2030) ($MN)
  • Table 5 Global Food Allergy Treatment Market Outlook, By Tree Nuts (2022-2030) ($MN)
  • Table 6 Global Food Allergy Treatment Market Outlook, By Peanuts (2022-2030) ($MN)
  • Table 7 Global Food Allergy Treatment Market Outlook, By Shellfish (2022-2030) ($MN)
  • Table 8 Global Food Allergy Treatment Market Outlook, By Wheat (2022-2030) ($MN)
  • Table 9 Global Food Allergy Treatment Market Outlook, By Soys (2022-2030) ($MN)
  • Table 10 Global Food Allergy Treatment Market Outlook, By Other Allergen Types (2022-2030) ($MN)
  • Table 11 Global Food Allergy Treatment Market Outlook, By Drug Type (2022-2030) ($MN)
  • Table 12 Global Food Allergy Treatment Market Outlook, By Antihistamines (2022-2030) ($MN)
  • Table 13 Global Food Allergy Treatment Market Outlook, By Decongestants (2022-2030) ($MN)
  • Table 14 Global Food Allergy Treatment Market Outlook, By Corticosteroids (2022-2030) ($MN)
  • Table 15 Global Food Allergy Treatment Market Outlook, By Mast Cell Stabilizers (2022-2030) ($MN)
  • Table 16 Global Food Allergy Treatment Market Outlook, By Leukotriene Inhibitors (2022-2030) ($MN)
  • Table 17 Global Food Allergy Treatment Market Outlook, By Nasal Anti-cholinergic (2022-2030) ($MN)
  • Table 18 Global Food Allergy Treatment Market Outlook, By Immuno-modulators (2022-2030) ($MN)
  • Table 19 Global Food Allergy Treatment Market Outlook, By Epinephrine (2022-2030) ($MN)
  • Table 20 Global Food Allergy Treatment Market Outlook, By Immunotherapy (2022-2030) ($MN)
  • Table 21 Global Food Allergy Treatment Market Outlook, By Other Drug Types (2022-2030) ($MN)
  • Table 22 Global Food Allergy Treatment Market Outlook, By Route of Administration (2022-2030) ($MN)
  • Table 23 Global Food Allergy Treatment Market Outlook, By Oral (2022-2030) ($MN)
  • Table 24 Global Food Allergy Treatment Market Outlook, By Parenteral (2022-2030) ($MN)
  • Table 25 Global Food Allergy Treatment Market Outlook, By Other Route of Administrations (2022-2030) ($MN)
  • Table 26 Global Food Allergy Treatment Market Outlook, By End User (2022-2030) ($MN)
  • Table 27 Global Food Allergy Treatment Market Outlook, By Hospital Pharmacies (2022-2030) ($MN)
  • Table 28 Global Food Allergy Treatment Market Outlook, By Retail Pharmacies (2022-2030) ($MN)
  • Table 29 Global Food Allergy Treatment Market Outlook, By Other End Users (2022-2030) ($MN)

Note: Tables for North America, Europe, APAC, South America, and Middle East & Africa Regions are also represented in the same manner as above.